Veeva Systems, Inc. engages in the provision of industry cloud solutions for the global life sciences industry. The firm's solutions enable pharmaceutical and other life sciences companies to realize ...

Veeva Systems Inc. (NYSE:VEEV), with significant hedge fund interest, ranks among the 10 best SaaS stocks to buy according to ...

The OpenAPI specification, and the Swagger suite of tools built around it, make it incredibly easy for Python developers to create, document and manually test the RESTful APIs they create. Regardless ...

A Wisconsin judge has dismissed a lawsuit against Epic that challenged the EHR vendor’s noncompete agreements. Judge David Conway of Dane County (Wis.) Circuit Court dismissed the case with prejudice ...

For years, Veeva's commercial software sat on top of Salesforce's (CRM 1.56%) infrastructure. While this enabled rapid scaling, it limited Veeva's control over its technical destiny and required ...

Veeva Systems is the latest tech company to be added to the S&P 500. Like other cloud software vendors, Veeva has been punished this year by investors concerned about threats from artificial ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Susan Dziubinski: Well, it’s time for our question of the week. Now, as a reminder, the best way to get your question answered is to email us at themorningfilter@morningstar.com. This week’s question ...

Veeva Systems, which offers life sciences companies cloud-based commercial management software and business consulting services, is venturing into the consumer-facing side of things with the ...

Veeva Systems has built its presence in brand engagement with the acquisition of Ostro, a tech start-up that helps pharma companies connect with doctors and patients using AI-powered conversational ...

Veeva Systems acquired Ostro, a platform that offers an artificial intelligence-driven chatbot for patients and doctors, in a deal valued at $100 million. The life sciences software and data company ...